Medicine Man Technologies, Inc.

OTCPK:SHWZ Stock Report

Market Cap: US$3.2m

Medicine Man Technologies Past Earnings Performance

Past criteria checks 0/6

Medicine Man Technologies's earnings have been declining at an average annual rate of -30.5%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been growing at an average rate of 45.1% per year.

Key information

-30.5%

Earnings growth rate

-8.0%

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth rate45.1%
Return on equity-65.7%
Net Margin-38.8%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Medicine Man Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SHWZ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24175-68790
31 Mar 24174-61750
31 Dec 23172-43710
30 Sep 23169-41700
30 Jun 23166-39690
31 Mar 231682660
31 Dec 22159-26590
30 Sep 221469520
30 Jun 2213410520
31 Mar 22121-18460
31 Dec 211087390
30 Sep 2190-7400
30 Jun 2165-11350
31 Mar 2140-22330
31 Dec 2024-19300
30 Sep 2019-14270
30 Jun 2015-13240
31 Mar 2012-15200
31 Dec 1911-17170
30 Sep 199-18110
30 Jun 199-1190
31 Mar 199-260
31 Dec 188150
30 Sep 187550
30 Jun 185-140
31 Mar 184-580
31 Dec 173-570
30 Sep 172-670
30 Jun 172-660
31 Mar 171-110
31 Dec 161-110
30 Sep 161010
30 Jun 161010
31 Mar 161010
31 Dec 151010
30 Sep 151010
31 Dec 140000

Quality Earnings: SHWZ is currently unprofitable.

Growing Profit Margin: SHWZ is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SHWZ is unprofitable, and losses have increased over the past 5 years at a rate of 30.5% per year.

Accelerating Growth: Unable to compare SHWZ's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SHWZ is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).


Return on Equity

High ROE: SHWZ has a negative Return on Equity (-65.73%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:19
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medicine Man Technologies, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell StanleyBeacon Securities Limited
Michael HickeyBenchmark Company
Jonathan DeCourceyBTIG